Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Marpai, Inc. (MRAI)
USD1.10
+0.35 (+46.67%)
US OTC Healthcare Medical - Healthcare Plans
Address
401 Park Avenue South 10016
New York City, NY, US
New York City, NY, US
CEO
Damien Francis Lamendola
Website
marpaihealth.com
IPO
2021-10-27
CIK 1844392 ISIN US5713542083
Description
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.10
+0.35 (+46.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
56.9K
Beta
4.92
Float Shares
3.08M
Free Float %
17.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.35% | +7.52% | +0.10% | -27.43% | -73.61% | -53.99% | -74.97% | -88.83% | -98.47% | -98.47% | -98.47% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
1.10
Low
6.00
+445.5%
Consensus
6.00
+445.5%
Median
6.00
+445.5%
High
6.00
+445.5%
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
6.00
+445.5%
|
Quality scores
Altman Z-Score
-19.54
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Plans: +11.8%-35.8% Q1'26: -18.0% (vs Q1'25)
-
EPS growth Medical - Healthcare Plans: -1.4%+50.5% ★ Q1'26: +38.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Plans: +15.1%-78.2% Q1'26: -10.7% (vs Q1'25)
-
EBIT margin Medical - Healthcare Plans: +3.3%-74.8% Q1'26: -55.9% (vs Q1'25)
-
ROIC Medical - Healthcare Plans: +6.7%— Q1'26: +28.6% (vs Q1'25)
-
Share dilution Medical - Healthcare Plans: +2.1%+50.9% Q1'26: +67.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Plans: 0.93×-0.74× Q1'26: -0.08× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|
| Revenue |
14.23M
est: 18.05M (-21.2%)
|
24.34M
est: 23.80M (+2.3%)
|
37.16M
est: 36.90M (+0.7%)
|
28.17M
est: 33.70M (-16.4%)
|
18.10M
est: 66.80M (-72.9%)
|
| EBITDA |
-13.65M
est: -8.38M (-62.8%)
|
-22.55M
est: -11.06M (-103.9%)
|
-22.12M
est: -17.14M (-29.0%)
|
-23.73M
est: -27.27M (+13.0%)
|
-13.09M
est: -54.06M (+75.8%)
|
| EBIT |
-15.71M
est: -9.61M (-63.4%)
|
-26.72M
est: -12.68M (-110.8%)
|
-27.51M
est: -19.65M (-40.0%)
|
-25.99M
est: -29.73M (+12.6%)
|
-13.53M
est: -58.93M (+77.0%)
|
| Net Income |
-15.99M
est: -66.30M (+75.9%)
|
-26.47M
est: -57.10M (+53.6%)
|
-28.75M
est: -28.20M (-1.9%)
|
-22.09M
est: -25.36M (+12.9%)
|
-16.56M
est: -6.60M (-150.9%)
|
| SGA |
13.02M
est: 14.14M (-7.9%)
|
19.26M
est: 18.65M (+3.3%)
|
25.77M
est: 28.92M (-10.9%)
|
14.60M
est: 24.22M (-39.7%)
|
12.23M
est: 48.02M (-74.5%)
|
| EPS |
-3.15
est: -5.76 (+45.3%)
|
-5.23
est: -4.96 (-5.4%)
|
-4.14
est: -2.45 (-69.0%)
|
-1.92
est: -1.46 (-31.5%)
|
-0.95
est: -0.38 (-150.0%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-8.53M
OE per share TTM
-0.46
Owner's Yield
-159.68%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
10.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
10
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Damien Lamendola | 6.25M | 31.10% | 6.25M | 7.83M | 6.25M | — | IN | — | 2022-02-01 | ↗ |
| 2 | WellEnterprises USA, LLC 46-0837544 | 3.73M | 18.50% | — | 7.83M | — | 3.73M | CO | — | 2022-02-01 | ↗ |
| 3 | HillCour Investment Fund, LLC 81-5352590 | 2.53M | 12.60% | — | 7.83M | — | 2.53M | CO | — | 2022-02-01 | ↗ |
| 4 | Altium Capital Management, LP | 1.81M | 6.20% | — | 1.81M | — | — | IA, PN | Delaware, United States of America | 2023-04-26 | ↗ |
| 5 | Altium Growth Fund, LP | 1.81M | 6.20% | — | 1.81M | — | — | PN | Delaware, United States of America | 2023-04-26 | ↗ |
| 6 | Altium Growth GP, LLC | 1.81M | 6.20% | — | 1.81M | — | — | OO | Delaware, United States of America | 2023-04-26 | ↗ |
| 7 | Edmundo Gonzalez | 1.52M | 7.53% | 1.52M | 7.83M | 1.52M | — | IN | — | 2021-12-30 | ↗ |
| 8 | Eli David | 913.3K | 4.50% | 913.3K | 7.83M | 913.3K | — | IN | — | 2021-12-21 | ↗ |
| 9 | Yaron Eitan | 852.6K | 4.20% | 852.6K | 7.83M | 852.6K | — | IN | — | 2021-12-21 | ↗ |
| 10 | Grays West Ventures LLC EIN: 46-5750310 | 692.8K | 3.40% | — | 7.83M | — | 692.8K | CO | — | 2021-12-30 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
9.00
Bullish
Ratio by volume
3.00
Bullish
Buys
9
Sells
1
Shares acquired
1.38M
Shares disposed
14.0K
Cash buys
—
Cash sales
1.00
Net activity
+1,361,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | SHIV SAGIV | Director | A-Award | A | Class A Common Stock | 100,000 | 0.00 | — | 522,000 | D | ↗ |
| 2025-11-07 | Scrip Dallas | Officer | P-Purchase | A | Common Warrants to purchase Shares of Common Stock | 200,000 | 1.00 | 200.0K | 200,000 | I | ↗ |
| 2025-11-07 | SHIV SAGIV | Director | P-Purchase | A | Class A Common Stock | 50,000 | 1.00 | 50.0K | 272,000 | D | ↗ |
| 2025-11-07 | PONS ROBERT M | Director | P-Purchase | A | Class A Common Stock | 50,000 | 1.00 | 50.0K | 359,200 | D | ↗ |
| 2025-11-07 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 100,000 | 1.00 | 100.0K | 1,089,073 | D | ↗ |
| 2025-10-20 | SHIV SAGIV | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 222,000 | D | ↗ |
| 2025-10-20 | PONS ROBERT M | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 209,200 | D | ↗ |
| 2025-10-20 | Lamendola Damien | Director / Officer / 10% Owner | A-Award | A | Class A Common Stock | 550,000 | 0.00 | — | 1,350,000 | D | ↗ |
| 2025-10-20 | Johnson Steve Andrew | Officer | A-Award | A | Class A Common Stock | 275,000 | 0.00 | — | 898,092 | D | ↗ |
| 2025-10-20 | EITAN YARON | Director | A-Award | A | Class A Common Stock | 125,000 | 0.00 | — | 989,073 | D | ↗ |
| 2025-10-20 | DiClaudio Colleen | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 142,500 | D | ↗ |
| 2025-10-20 | Calabrese Jennifer Rosario | Director | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 175,000 | D | ↗ |
| 2025-10-06 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 14,000 | 1.63 | 22.8K | 1,770,707 | I | ↗ |
| 2025-09-30 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 147,058 | 1.36 | 200.0K | 6,419,893 | I | ↗ |
| 2025-09-10 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 896,903 | 1.06 | 950.0K | 6,272,835 | I | ↗ |
| 2025-08-20 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 10,000 | 1.42 | 14.2K | 1,784,707 | I | ↗ |
| 2025-08-19 | SHIV SAGIV | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 147,000 | D | ↗ |
| 2025-08-19 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 20,000 | 1.40 | 28.0K | 1,794,707 | I | ↗ |
| 2025-08-19 | EITAN YARON | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 864,073 | D | ↗ |
| 2025-08-19 | Calabrese Jennifer Rosario | Director | A-Award | A | Class A Common Stock | 75,000 | 0.00 | — | 125,000 | D | ↗ |
| 2025-08-18 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 20,000 | 1.40 | 28.0K | 1,814,707 | I | ↗ |
| 2025-08-15 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 20,000 | 1.40 | 28.0K | 1,834,707 | I | ↗ |
| 2025-08-13 | Intelligent Fanatics Capital Management LLC | 10% Owner | S-Sale | D | Common Shares, par value $0.0001 | 10,000 | 1.43 | 14.3K | 1,854,707 | I | ↗ |
| 2025-07-29 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 371,470 | 1.08 | 400.0K | 5,375,932 | I | ↗ |
| 2025-07-17 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 86,805 | 1.15 | 100.0K | 5,004,462 | I | ↗ |
| 2025-06-09 | Scrip Dallas | Officer | A-Award | A | Class A Common Stock | 300,000 | 0.00 | — | 300,000 | D | ↗ |
| 2025-06-09 | Powers John Paul | Officer | A-Award | A | Class A Common Stock | 150,000 | 0.00 | — | 410,000 | D | ↗ |
| 2025-06-09 | Johnson Steve Andrew | Officer | A-Award | A | Class A Common Stock | 150,000 | 0.00 | — | 623,061 | D | ↗ |
| 2025-05-13 | Scrip Dallas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-28 | Lamendola Damien | Director / Officer / 10% Owner | A-Award | A | Class A Common Stock | 600,000 | 0.00 | — | 5,517,657 | I | ↗ |
| 2024-12-05 | Powers John Paul | Officer | P-Purchase | A | Class A Common Stock | 10,000 | 1.13 | 11.3K | 260,000 | D | ↗ |
| 2024-12-05 | Johnson Steve Andrew | Officer | P-Purchase | A | Class A Common Stock | 5,000 | 1.13 | 5.7K | 473,061 | D | ↗ |
| 2024-12-05 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 110,619 | 1.13 | 125.0K | 789,073 | D | ↗ |
| 2024-12-03 | Intelligent Fanatics Capital Management LLC | 10% Owner | — | — | Common Shares, par value $0.0001 | 0 | 0.00 | — | 1,864,707 | D | ↗ |
| 2024-08-28 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 1,351,351 | 0.48 | 650.0K | 4,917,657 | — | ↗ |
| 2024-06-03 | EITAN YARON | Director | A-Award | A | Class A Common Stock | 7,000 | 0.61 | 4.3K | 673,454 | — | ↗ |
| 2024-05-29 | Moazami Mohsen | Director | S-Sale | D | Class A Common Stock | 15,000 | 0.68 | 10.2K | 35,000 | — | ↗ |
| 2024-05-29 | Johnson Steve Andrew | Officer | P-Purchase | A | Class A Common Stock | 3,500 | 0.65 | 2.3K | 368,061 | — | ↗ |
| 2024-05-28 | PONS ROBERT M | Director | P-Purchase | A | Class A Common Stock | 5,000 | 0.87 | 4.4K | 84,200 | — | ↗ |
| 2024-05-24 | Powers John Paul | Officer | A-Award | A | Class A Common Stock | 100,000 | 0.00 | — | 250,000 | D | ↗ |
| 2024-05-24 | Johnson Steve Andrew | Officer | A-Award | A | Class A Common Stock | 100,000 | 0.00 | — | 468,061 | D | ↗ |
| 2024-05-24 | EITAN YARON | Director | A-Award | A | Class A Common Stock | 5,000 | 0.00 | — | 678,454 | D | ↗ |
| 2024-05-23 | SHIV SAGIV | Director | A-Award | A | Class A Common Stock | 60,000 | 0.00 | — | 60,000 | — | ↗ |
| 2024-05-23 | Moazami Mohsen | Director | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2024-05-23 | Lamendola Damien | Director / Officer / 10% Owner | A-Award | A | Class A Common Stock | 600,000 | 0.00 | — | 3,461,306 | — | ↗ |
| 2024-05-23 | Johnson Steve Andrew | Officer | A-Award | A | Class A Common Stock | 350,000 | 0.00 | — | 359,561 | — | ↗ |
| 2024-05-23 | EITAN YARON | Director | A-Award | A | Class A Common Stock | 60,000 | 0.00 | — | 666,454 | — | ↗ |
| 2024-05-23 | DiClaudio Colleen | Director | A-Award | A | Class A Common Stock | 60,000 | 0.00 | — | 60,000 | — | ↗ |
| 2024-05-16 | PONS ROBERT M | Director | P-Purchase | A | Class A Common Stock | 5,000 | 2.10 | 10.5K | 79,200 | — | ↗ |
| 2024-05-10 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 10,000 | 2.49 | 24.9K | 210,000 | — | ↗ |
| 2024-05-10 | Johnson Steve Andrew | Officer | A-Award | A | Class A Common Stock | 5,000 | 2.60 | 13.0K | 9,561 | — | ↗ |
| 2024-05-10 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 5,000 | 2.66 | 13.3K | 606,454 | — | ↗ |
| 2024-05-10 | Dendy Michael Charles | Director | S-Sale | D | Class A Common Stock | 2,371 | 2.40 | 5.7K | 17,629 | — | ↗ |
| 2024-03-07 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 910,000 | 1.65 | 1.50M | 2,861,306 | — | ↗ |
| 2024-01-17 | PONS ROBERT M | Director | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 74,200 | — | ↗ |
| 2024-01-17 | Dendy Michael Charles | Director | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 103,850 | — | ↗ |
| 2024-01-17 | Calabrese Jennifer Rosario | Director | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2024-01-16 | PONS ROBERT M | Director | P-Purchase | A | Class A Common Stock | 12,100 | 0.92 | 11.1K | 24,200 | — | ↗ |
| 2024-01-16 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 1,100,000 | 0.92 | 1.01M | 1,951,306 | — | ↗ |
| 2024-01-16 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 210,000 | 0.92 | 193.2K | 601,454 | — | ↗ |
| 2024-01-11 | Powers John Paul | Officer | A-Award | A | Class A Common Stock | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2023-12-14 | PONS ROBERT M | Director | P-Purchase | A | Class A Common Stock | 12,100 | 1.81 | 21.9K | 12,100 | — | ↗ |
| 2023-12-14 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 150,000 | 1.97 | 295.5K | 851,306 | — | ↗ |
| 2023-12-14 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 50,000 | 1.97 | 98.5K | 391,454 | — | ↗ |
| 2023-12-07 | PONS ROBERT M | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-07 | Calabrese Jennifer Rosario | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-21 | Lamendola Damien | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 200,000 | 1.19 | 238.7K | 200,000 | — | ↗ |
| 2023-11-17 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 100,000 | 1.23 | 123.0K | 341,454 | — | ↗ |
| 2023-11-13 | Dendy Michael Charles | Director | — | I | Class A Common Stock | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2023-11-06 | Johnson Steve Andrew | Officer | — | D | Class A Common Stock | 0 | 0.00 | — | 4,591 | — | ↗ |
| 2023-11-06 | Dendy Michael Charles | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 53,850 | — | ↗ |
| 2023-09-11 | Gonzalez Edmundo | Director / Officer | P-Purchase | A | Class A Common Stock | 42,000 | 0.77 | 32.3K | 264,047 | — | ↗ |
| 2023-06-21 | Gonzalez Edmundo | Director / Officer | P-Purchase | A | Class A Common Stock | 20,000 | 0.51 | 10.1K | 888,189 | — | ↗ |
| 2023-02-01 | SHIV SAGIV | Director | — | D | No Securities Beneficially Owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-01 | Antebi Gonen | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 0.93 | 279.0K | 300,000 | — | ↗ |
| 2023-01-04 | Bibring Yoram | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2022-12-09 | Finger Lutz | Officer | D-Return | D | Class A Common Stock | 140,614 | 0.00 | — | 1,205,540 | — | ↗ |
| 2022-11-16 | Gonzalez Edmundo | Officer | P-Purchase | A | Class A Common Stock | 8,110 | 0.96 | 7.8K | 868,189 | — | ↗ |
| 2022-11-15 | Gonzalez Edmundo | Officer | P-Purchase | A | Class A Common Stock | 1,000 | 0.93 | 930.00 | 860,079 | — | ↗ |
| 2022-09-12 | Lamendola Damien | Director / 10% Owner | P-Purchase | A | Class A Common Stock | 100,000 | 1.00 | 99.7K | 2,805,223 | — | ↗ |
| 2022-08-22 | Lamendola Damien | Director | P-Purchase | A | Class A Common Stock | 135,944 | 1.12 | 151.9K | 2,705,223 | — | ↗ |
| 2022-08-18 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 175,000 | 0.79 | 138.3K | 965,816 | — | ↗ |
| 2022-08-17 | Lamendola Damien | Director | P-Purchase | A | Class A Common Stock | 90,529 | 0.76 | 68.6K | 2,287,968 | — | ↗ |
| 2022-08-17 | Kane Vincent | Director | P-Purchase | A | Class A Common Stock | 5,000 | 0.78 | 3.9K | 69,669 | — | ↗ |
| 2022-08-17 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 31,000 | 0.79 | 24.5K | 790,816 | — | ↗ |
| 2022-06-14 | Moazami Mohsen | Director | A-Award | A | Stock Option (Right to Buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-06-14 | Lamendola Damien | Director | A-Award | A | Stock Option (Right to Buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-06-14 | Kane Vincent | Director | A-Award | A | Stock Option (Right to Buy) | 120,330 | 0.00 | — | 120,330 | — | ↗ |
| 2022-06-14 | Gonzalez Edmundo | Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-06-14 | Finger Lutz | Officer | A-Award | A | Class A Common Stock | 1,346,154 | 0.00 | — | 1,346,154 | — | ↗ |
| 2022-06-14 | EITAN YARON | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2022-06-14 | DiClaudio Colleen | Director | A-Award | A | Stock Option (Right to Buy) | 175,000 | 1.11 | 194.3K | 175,000 | — | ↗ |
| 2022-06-14 | Bibring Yoram | Officer | A-Award | A | Stock Option (Right to Buy) | 30,615 | 0.00 | — | 30,615 | — | ↗ |
| 2022-06-14 | Antebi Gonen | Director | A-Award | A | Stock Option (Right to Buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-05-23 | Gonzalez Edmundo | Officer | P-Purchase | A | Class A Common Stock | 7,999 | 1.49 | 11.9K | 859,079 | — | ↗ |
| 2022-05-19 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 32,274 | 1.64 | 52.8K | 759,816 | — | ↗ |
| 2022-05-18 | Gonzalez Edmundo | Officer | P-Purchase | A | Class A Common Stock | 9,000 | 1.19 | 10.7K | 849,079 | — | ↗ |
| 2022-05-18 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 271 | 1.35 | 364.85 | 690,310 | — | ↗ |
| 2022-05-18 | Brown Ronnie | Officer | P-Purchase | A | Class A Common Stock | 694 | 1.44 | 998.39 | 694 | — | ↗ |
| 2022-05-16 | Kane Vincent | Director | P-Purchase | A | Class A Common Stock | 10,000 | 1.05 | 10.5K | 64,669 | — | ↗ |
| 2022-05-16 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 13,042 | 1.22 | 15.9K | 690,039 | — | ↗ |
| 2022-03-30 | Moazami Mohsen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-28 | Finger Lutz | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-22 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 10,000 | 2.05 | 20.5K | 659,816 | — | ↗ |
| 2021-12-15 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 400 | 4.17 | 1.7K | 649,816 | — | ↗ |
| 2021-12-15 | Bibring Yoram | Officer | P-Purchase | A | Class A Common Stock | 5,000 | 4.33 | 21.7K | 5,000 | — | ↗ |
| 2021-12-14 | Lamendola Damien | Director / 10% Owner | X-InTheMoney | A | Class A Common Stock | 225,000 | 4.00 | 900.0K | 2,162,968 | — | ↗ |
| 2021-12-14 | Gonzalez Edmundo | Director / Officer | P-Purchase | A | Class A Common Stock | 17,500 | 4.20 | 73.5K | 840,079 | — | ↗ |
| 2021-12-14 | EITAN YARON | Director | P-Purchase | A | Class A Common Stock | 24,600 | 4.28 | 105.3K | 649,416 | — | ↗ |
| 2021-12-14 | Cavalier Jane | Director | P-Purchase | A | Class A Common Stock | 5,730 | 4.42 | 25.3K | 33,634 | — | ↗ |
| 2021-10-26 | Lamendola Damien | Director / 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 1,937,968 | — | ↗ |
| 2021-10-26 | Kane Vincent | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 54,670 | — | ↗ |
| 2021-10-26 | Hoath Art | Officer | — | D | Options | 182,233 | 2.58 | 470.2K | 0 | — | ↗ |
| 2021-10-26 | Gonzalez Edmundo | Director / Officer | — | D | Class A Common Stock | 0 | 0.00 | — | 822,579 | — | ↗ |
| 2021-10-26 | EITAN YARON | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 624,816 | — | ↗ |
| 2021-10-26 | DiClaudio Colleen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-26 | David Eli | — | — | D | Class A Common Stock | 0 | 0.00 | — | 685,482 | — | ↗ |
| 2021-10-26 | Cavalier Jane | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 27,904 | — | ↗ |
| 2021-10-26 | Brown Ronnie | Officer | — | D | Options | 91,116 | 2.58 | 235.1K | 0 | — | ↗ |
| 2021-10-26 | Bibring Yoram | Officer | — | D | Options | 80,000 | 4.00 | 320.0K | 0 | — | ↗ |
| 2021-10-26 | Antebi Gonen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Lamendola Damien | Director / 10% Owner | — | I | Warrants | 225,000 | 4.00 | 900.0K | 0 | — | ↗ |
| 2021-04-01 | Johnson Steve Andrew | Officer | — | D | Warrant (right to buy) | 11,390 | 31.61 | 360.0K | 0 | — | ↗ |
| 2021-02-09 | Gonzalez Edmundo | Director / Officer | — | I | Warrants | 379,650 | 7.90 | 3.00M | 0 | — | ↗ |
| 2021-02-09 | EITAN YARON | Director | — | D | Warrants | 227,791 | 7.90 | 1.80M | 0 | — | ↗ |
| 2021-02-09 | David Eli | — | — | D | Warrants | 227,791 | 7.90 | 1.80M | 0 | — | ↗ |
| 2020-01-17 | Lamendola Damien | Director / 10% Owner | — | I | Warrants | 364,466 | 1.43 | 521.2K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-115.7K
Shares Outstanding
17.37M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Damien Lamendola, Chief Executive Officer and Director | — | — | 362.00 | — | — | — | 362.00 | 100.00% | ↗ |
| 2 | 2024 | Steve Johnson, Chief Financial Officer | 39.00 | — | 211.00 | — | — | — | 250.00 | 84.40% | ↗ |
| 3 | 2024 | John Powers, President and Chief Operating Officer | 150.00 | — | 78.00 | — | — | — | 228.00 | 34.21% | ↗ |
| 4 | 2024 | Gonen Antebi, Chief Operating Officer | 36.00 | — | — | — | — | — | 36.00 | 0.00% | ↗ |
| 5 | 2023 | Lutz Finger, President, Product and Development | 203.00 | 125.00 | 491.00 | — | — | 772.00 | 1.6K | 30.86% | ↗ |
| 6 | 2023 | Gonen Antebi, Chief Operating Officer | 298.00 | — | 107.00 | — | — | — | 405.00 | 26.42% | ↗ |
| 7 | 2023 | Edmundo Gonzalez, Chief Executive Officer and Director | 292.00 | — | — | — | — | — | 292.00 | 0.00% | ↗ |
| 8 | 2023 | Yoram Bibring, Chief Financial Officer | 223.00 | — | 66.00 | — | — | — | 289.00 | 22.84% | ↗ |
| 9 | 2022 | Lutz Finger, President, Product and Development | 275.0K | — | 1.49M | — | — | 450.0K | 2.22M | 67.33% | ↗ |
| 10 | 2022 | Edmundo Gonzalez, Chief Executive Officer and Director | 363.5K | — | 212.6K | — | — | — | 576.1K | 36.91% | ↗ |
| 11 | 2022 | Yoram Bibring, Chief Financial Officer | 264.8K | 50.0K | 137.9K | — | — | — | 452.7K | 30.47% | ↗ |
| 12 | 2021 | Arthur Hoath, IV, Chief Revenue Officer | 293.4K | — | — | — | — | — | 293.4K | 0.00% | ↗ |
| 13 | 2021 | Edmundo Gonzalez, Chief Executive Officer and Director | 218.1K | — | — | — | — | 69.7K | 287.8K | 0.00% | ↗ |
| 14 | 2021 | Mordechai Geva, Former Chief Technology Officer | 218.1K | — | — | — | — | 69.7K | 287.8K | 0.00% | ↗ |
| 15 | 2021 | Yoram Bibring, Chief Financial Officer | 76.5K | 50.0K | — | — | — | — | 126.5K | 0.00% | ↗ |
| 16 | 2020 | Mordechai Geva, Former Chief Technology Officer | 226.4K | — | — | — | — | — | 226.4K | 0.00% | ↗ |
| 17 | 2020 | Edmundo Gonzalez, Chief Executive Officer and Director | — | — | — | — | — | 181.5K | 181.5K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Steve Johnson | Chief Financial Officer & Company Secretary | 59.0K | male |
| Damien Francis Lamendola | President, CEO & Director | — | male |
| Mimi Davis | President of MarpaiRx | — | female |
| Richard Brewer | Chief Strategy Officer | — | male |
| Yaron I. Eitan | Co-Founder & Independent Chairman of the Board | — | male |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE PLANS
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRAI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
